US OptionsDetailed Quotes

TGTX250509C45500

Watchlist

2.20
0.000.00%

15min DelayClose May 8 16:00 ET

0.00High0.00Low

TG Therapeutics Stock Discussion

Sign in to post a comment

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

$TG Therapeutics (TGTX.US)$
TG Therapeutics Crushes Earnings: MS Drug BRIUMVI Drives 137% Growth, Company Turns Profitable

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

$TG Therapeutics (TGTX.US)$
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

$TG Therapeutics (TGTX.US)$
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

$TG Therapeutics (TGTX.US)$
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

$TG Therapeutics (TGTX.US)$
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

$TG Therapeutics (TGTX.US)$
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

strong performing

$TG Therapeutics (TGTX.US)$ 42

1

Nov 29, 2024 23:55

Share Your Profit/Loss

16

Nov 29, 2024 21:16

$TG Therapeutics (TGTX.US)$

2

frogoracletrading

Oct 29, 2024 21:19

$TGTX Support / Resistance Levels

Here are the levels to watch on this move up.
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$

$TGTX Support / Resistance Levels

2

No comment yet